Connect with us:
Moving to the forefront
With a presence of over two decades in the United Kingdom, Ipca has gained insightful knowledge of the market dynamics and its competencies. A majority of Ipca’s products are backward integrated with its own APIs, and with 12 facilities manufacturing APIs and Intermediates, there is an ensured consistency and reliability in the supply chain.
By augmenting capabilities and scaling operations, Ipca is now set to take its journey to the forefront to compete in the growing generic arena with more than a dozen products awaiting to be launched in the UK, in the near future.
If you would like to know more about our products please speak to your wholesaler or get in touch with us at firstname.lastname@example.org.
Indications: To treat Rheumatoid Arthritis and Lupus
|Description||White, circular, biconvex film-coated tablets, approx. 9.5mm in diameter|
|Shelf Life||3 Years|
|Pack Size||60 Tablets|
|MA Holder||Ipca Laboratories UK Ltd., backed by API from Ipca India|
|Drug Tariff||Category M|
|Brand | Originator||Plaquenil® | Sanofi|
|Product Type||Primarily Retail Pharmacy Product (100%)|
|PL Number||PL 28278/0023|
|Pallet Size||BS 2629 – 1200 x 1000 x 95 mm|